Sagittarius Life Science Corp (3205.TWO)

Sagittarius Life Science Corp (3205.TWO) — VMCI valuation read

3205.TWO prints VMCI 41/100 inside the Healthcare sector, where the median sits at 50. The 9-point below-median delta is the cleanest single-number summary of Sagittarius Life Science Corp's composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On 3205.TWO, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** 3205.TWO trades at 24.0x earnings, 33% above the Healthcare median of 18.0x; that is the value line. ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -1.8x leaves covenant headroom; that is the risk line for Sagittarius Life Science Corp on the trailing financials.

3205.TWO fell 4.0% over the trailing 7 days, with a -13.1% read on a 30-day basis.